Double drug combo could shut down abnormal blood vessel growth
- Details
- Category: Research
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
Large lung cancer study shows potential for more targeted therapies
- Details
- Category: Research
A nationwide consortium of scientists has reported the first comprehensive genetic analysis of squamous cell carcinoma of the lung, a common type of lung cancer responsible for about 400,000 deaths each year.
Nutritional supplement offers promise in treatment of unique form of autism
- Details
- Category: Research
An international team of researchers, led by scientists at the University of California, San Diego and Yale University schools of medicine, have identified a form of autism with epilepsy that may potentially be treatable with a common nutritional supplement.
Male birth control pill may be ready soon
- Details
- Category: Research
Attention men: The day may be coming soon when you can take your own birth control pill with no side effects, according to a study done by a group of scientists that includes a Texas A&M University researcher.
Targeting inflammation to treat depression
- Details
- Category: Research
Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of General Psychiatry.
Cleveland Clinic researchers investigating potential drug for treatment of Alzheimer's disease
- Details
- Category: Research
A compound developed to treat neuropathic pain has shown potential as an innovative treatment for Alzheimer's disease, according to a study by researchers at Cleveland Clinic's Lerner Research Institute and Anesthesiology Institute.
Possible therapy for tamoxifen-resistant breast cancer identified
- Details
- Category: Research
A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate. It also suggests that an experimental agent might offer a novel targeted therapy for tamoxifen-resistant breast cancer.
More Pharma News ...
- Chocolate: A sweet method for stroke prevention in men?
- Omission of aspirin from antiplatelet regimen: The WOEST study
- Anti-clotting drugs yield similar results
- Potency of statins linked to muscle side effects
- First evidence from humans on how alcohol may boost risk of cancer
- Common antifungal drug decreases tumor growth and shows promise as cancer therapy
- Statin therapy associated with lower risk of pancreatitis